Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Express Scripts
Covington
Fuji
Mallinckrodt
Deloitte
Boehringer Ingelheim
Argus Health
Queensland Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,681,590

« Back to Dashboard

Summary for Patent: 5,681,590
Title: Dry mix formulation for bisphosphonic acids
Abstract:Pharmaceutical compositions of bisphosphonic acids, and salts thereof, are prepared by direct compression/dry mix tablet formulation. These pharmaceutical compositions are useful in the treatment of disturbances involving calcium or phosphate metabolism, in particular, the treatment and prevention of diseases involving bone resorption, especially osteoporosis, Paget's disease, malignant hypercalcemia, and metastatic bone disease.
Inventor(s): Bechard; Simon R. (Quebec, CA), Kramer; Kenneth A. (Green Lane, PA), Katdare; Ashok V. (Norristown, PA)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:08/454,100
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 5,681,590
Patent Claim Types:
see list of patent claims
Dosage form; Process; Composition;

Drugs Protected by US Patent 5,681,590

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,681,590

PCT Information
PCT FiledNovember 17, 1993PCT Application Number:PCT/US93/11172
PCT Publication Date:June 09, 1994PCT Publication Number: WO94/12200

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Department of Justice
US Army
QuintilesIMS
AstraZeneca
Julphar
Teva
Harvard Business School
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.